Kersten Dirk's Form 4 filing
Dyne Therapeutics, Inc. (DYN) · filed Jun 24, 2026
- Accession no.
- 0001193125-26-281119
- Filed
- Jun 24, 2026
- Trade date
- Jun 22-23, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $5.46M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kersten DirkCIK 0001823682 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Common Stock | SSaleDisposed | −190,676 | $20.57 | −$3,922,205.32 | 3,921,542 | Indirect | |
| Jun 23, 2026 | Common Stock | SSaleDisposed | −71,629 | $21.04 | −$1,507,074.16 | 3,849,913 | Indirect | |
| Jun 23, 2026 | Common Stock | SSaleDisposed | −1,657 | $21.47 | −$35,575.79 | 3,848,256 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.